Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
Abstract Osteoporosis, characterized by bone mass reduction and increased fractures, has become a global health problem that seriously affects the health of people, especially postmenopausal women; however, the current pathogenesis of postmenopausal osteoporosis (PMOP) has not been thoroughly elucid...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1897ce3a0b6f4955bd4551d6495da09f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1897ce3a0b6f4955bd4551d6495da09f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1897ce3a0b6f4955bd4551d6495da09f2021-12-02T15:08:57ZIntegrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model10.1038/s41598-018-34574-62045-2322https://doaj.org/article/1897ce3a0b6f4955bd4551d6495da09f2018-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-34574-6https://doaj.org/toc/2045-2322Abstract Osteoporosis, characterized by bone mass reduction and increased fractures, has become a global health problem that seriously affects the health of people, especially postmenopausal women; however, the current pathogenesis of postmenopausal osteoporosis (PMOP) has not been thoroughly elucidated to date. In this study, bilateral ovariectomy was performed to establish an OVX mouse model of osteoporosis. UPLC-Q-TOF-MS-based lipidomics in combination with metabolomics were used to analyze the femur tissue of osteoporosis mice. We found that 11 polar metabolites and 93 lipid metabolites were significantly changed and were involved in amino acid metabolism, nucleotide metabolism and lipid metabolism. Among the lipids, fatty acyls, glycerolipids, glycerophospholipids, sphingolipids and sterols showed robust changes. These results revealed that several metabolic disorders caused by changes in the hormone levels in OVX, especially disordered lipid metabolism, are closely related to the imbalance between bone resorption and formation and may underlie the development of PMOP. The data generated via lipidomics and metabolomics presented in this study shows good applicability and wide coverage in the construction of the metabolic profile of bone tissue. Therefore, this approach may provide the pathway focusing and data support at the metabolite level for the in-depth mechanism of PMOP.Hongxia ZhaoXiaoqun LiDianying ZhangHaiyan ChenYufan ChaoKaiwen WuXin DongJiacan SuNature PortfolioarticleOsteoporosis MicePostmenopausal OsteoporosisGlycerophospholipidsBone Volume/total Volume (BV/TV)Lipidomic AnalysisMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Osteoporosis Mice Postmenopausal Osteoporosis Glycerophospholipids Bone Volume/total Volume (BV/TV) Lipidomic Analysis Medicine R Science Q |
spellingShingle |
Osteoporosis Mice Postmenopausal Osteoporosis Glycerophospholipids Bone Volume/total Volume (BV/TV) Lipidomic Analysis Medicine R Science Q Hongxia Zhao Xiaoqun Li Dianying Zhang Haiyan Chen Yufan Chao Kaiwen Wu Xin Dong Jiacan Su Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model |
description |
Abstract Osteoporosis, characterized by bone mass reduction and increased fractures, has become a global health problem that seriously affects the health of people, especially postmenopausal women; however, the current pathogenesis of postmenopausal osteoporosis (PMOP) has not been thoroughly elucidated to date. In this study, bilateral ovariectomy was performed to establish an OVX mouse model of osteoporosis. UPLC-Q-TOF-MS-based lipidomics in combination with metabolomics were used to analyze the femur tissue of osteoporosis mice. We found that 11 polar metabolites and 93 lipid metabolites were significantly changed and were involved in amino acid metabolism, nucleotide metabolism and lipid metabolism. Among the lipids, fatty acyls, glycerolipids, glycerophospholipids, sphingolipids and sterols showed robust changes. These results revealed that several metabolic disorders caused by changes in the hormone levels in OVX, especially disordered lipid metabolism, are closely related to the imbalance between bone resorption and formation and may underlie the development of PMOP. The data generated via lipidomics and metabolomics presented in this study shows good applicability and wide coverage in the construction of the metabolic profile of bone tissue. Therefore, this approach may provide the pathway focusing and data support at the metabolite level for the in-depth mechanism of PMOP. |
format |
article |
author |
Hongxia Zhao Xiaoqun Li Dianying Zhang Haiyan Chen Yufan Chao Kaiwen Wu Xin Dong Jiacan Su |
author_facet |
Hongxia Zhao Xiaoqun Li Dianying Zhang Haiyan Chen Yufan Chao Kaiwen Wu Xin Dong Jiacan Su |
author_sort |
Hongxia Zhao |
title |
Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model |
title_short |
Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model |
title_full |
Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model |
title_fullStr |
Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model |
title_full_unstemmed |
Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model |
title_sort |
integrative bone metabolomics—lipidomics strategy for pathological mechanism of postmenopausal osteoporosis mouse model |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/1897ce3a0b6f4955bd4551d6495da09f |
work_keys_str_mv |
AT hongxiazhao integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel AT xiaoqunli integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel AT dianyingzhang integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel AT haiyanchen integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel AT yufanchao integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel AT kaiwenwu integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel AT xindong integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel AT jiacansu integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel |
_version_ |
1718387923093553152 |